Literature DB >> 9692752

Regional distribution of neuropeptide Y Y2 receptor messenger RNA in the human post mortem brain.

L Caberlotto1, K Fuxe, J M Rimland, G Sedvall, Y L Hurd.   

Abstract

The neuropeptide Y Y2 receptor is one of six receptor subtypes mediating the multiform physiological actions of neuropeptide Y. The Y2 receptor has been demonstrated to be the most predominant receptor subtype in the human brain and appears to be involved in many neuropeptide Y actions, such as the regulation of locomotor activity, cardiovascular functions, memory processing, circadian rhythms and release of other neurotransmitters. We have recently demonstrated the widespread and abundant distribution of neuropeptide Y Y1 receptor messenger RNA in the human cerebral cortex (different laminar patterns within distinct cortical regions), hippocampal dentate gyrus and striatum. To assess a possible differential distribution of Y1 and Y2 receptor messenger RNAs, the regional expression of neuropeptide Y Y2 messenger RNA-containing cells in the human brain was analysed, in particular within the cerebral cortex and striatum. In situ hybridization experiments revealed the localization of the Y2 messenger RNA signal throughout all cortical regions, with the highest intensity per cell apparent in lamina IV, with the exception of the striate cortex, which showed an intense labelling primarily in layer VI. The striatum expressed low to undetectable levels of the Y2 receptor messenger RNA. The dentate gyrus and the CA2 region presented the highest hybridization signals, while a very weak Y2 messenger RNA expression was found in the CA1 region and subiculum. Positive Y2 messenger RNA hybridization signals were also detected in the lateral geniculate nucleus, amygdala, substantia nigra, hypothalamus, cerebellum and choroid plexus. These results demonstrate the widespread distribution of neuropeptide Y Y2 receptor messenger RNA in the human brain, with a pattern of expression distinct from the Y1 subtype, suggesting that these two receptor subtypes may mediate different neuropeptide Y functions in the human brain, mainly through actions on different neuronal systems.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9692752     DOI: 10.1016/s0306-4522(98)00039-6

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  8 in total

1.  Conservation of expression of neuropeptide Y5 receptor between human and rat hypothalamus and limbic regions suggests an integral role in central neuroendocrine control.

Authors:  K A Nichol; A Morey; M H Couzens; J Shine; H Herzog; A M Cunningham
Journal:  J Neurosci       Date:  1999-12-01       Impact factor: 6.167

2.  [(125)I]-GR231118: a high affinity radioligand to investigate neuropeptide Y Y(1) and Y(4) receptors.

Authors:  Y Dumont; R Quirion
Journal:  Br J Pharmacol       Date:  2000-01       Impact factor: 8.739

3.  Plasticity of Y1 and Y2 receptors and neuropeptide Y fibers in patients with temporal lobe epilepsy.

Authors:  S Furtinger; S Pirker; T Czech; C Baumgartner; G Ransmayr; G Sperk
Journal:  J Neurosci       Date:  2001-08-01       Impact factor: 6.167

Review 4.  Cholinergic regulation of fear learning and extinction.

Authors:  Marlene A Wilson; Jim R Fadel
Journal:  J Neurosci Res       Date:  2016-10-05       Impact factor: 4.164

5.  Ventromedial hypothalamic NPY Y2 receptor in the maintenance of body weight in diet-induced obesity in mice.

Authors:  Xu-Feng Huang; Yinghua Yu; Yulin Li; South Tim; Chao Deng; Qing Wang
Journal:  Neurochem Res       Date:  2008-03-21       Impact factor: 3.996

6.  Modulation of methamphetamine-induced nitric oxide production by neuropeptide Y in the murine striatum.

Authors:  Haley L Yarosh; Jesus A Angulo
Journal:  Brain Res       Date:  2012-09-13       Impact factor: 3.252

Review 7.  Gut-brain peptides in corticostriatal-limbic circuitry and alcohol use disorders.

Authors:  Chelsea A Vadnie; Jun Hyun Park; Noha Abdel Gawad; Ada Man Choi Ho; David J Hinton; Doo-Sup Choi
Journal:  Front Neurosci       Date:  2014-09-18       Impact factor: 4.677

Review 8.  Ligands of the Neuropeptide Y Y2 Receptors as a Potential Multitarget Therapeutic Approach for the Protection of the Neurovascular Unit Against Acute Ischemia/Reperfusion: View from the Perspective of the Laboratory Bench.

Authors:  Łukasz Przykaza; Ewa Kozniewska
Journal:  Transl Stroke Res       Date:  2021-07-22       Impact factor: 6.829

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.